Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-24-000195

COFO and Secretary sold 8,353 shares at an average $23.99 ($200,401)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Schuth Alexander O. COFO and Secretary 2024-08-20 Sale 10b5-1 −2,453 $23.79 $58,357 183,966 D
Schuth Alexander O. COFO and Secretary 2024-08-20 Sale 10b5-1 −3,353 $23.54 $78,930 180,613 D
Schuth Alexander O. COFO and Secretary 2024-08-21 Sale 10b5-1 −2,547 $24.78 $63,115 178,066 D
Open-market sales · 8,353 sh · avg $23.99 · $200,401
Loading xslF345X05/wk-form4_1724357674.xml…